barbital has been researched along with Cancer of Liver in 8 studies
5,5-diethylbarbituric acid : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by two ethyl groups. Formerly used as a hypnotic (sleeping aid).
| Excerpt | Relevance | Reference |
|---|---|---|
| "In PB- and BS-treated livers, hepatomegaly was attributable to hepatocyte proliferation and enzyme induction." | 1.31 | Apoptosis and cell proliferation in rat hepatocytes induced by barbiturates. ( Fujieda, Y; Furukawa, S; Goryo, M; Hayashi, K; Ikeyama, S; Miyamoto, Y; Okada, K; Tamura, T; Usuda, K, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (50.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furukawa, F | 1 |
| Toyoda, K | 1 |
| Kokubo, T | 1 |
| Takahashi, M | 1 |
| Hayashi, Y | 1 |
| Diwan, BA | 5 |
| Anderson, LM | 2 |
| Ward, JM | 3 |
| Henneman, JR | 2 |
| Rice, JM | 5 |
| Riggs, CW | 1 |
| Logsdon, D | 1 |
| Haines, DC | 1 |
| Olivero, OA | 1 |
| Yuspa, SH | 1 |
| Poirier, MC | 1 |
| Furukawa, S | 1 |
| Usuda, K | 1 |
| Fujieda, Y | 1 |
| Tamura, T | 1 |
| Miyamoto, Y | 1 |
| Hayashi, K | 1 |
| Ikeyama, S | 1 |
| Goryo, M | 1 |
| Okada, K | 1 |
| Waalkes, MP | 1 |
| Weghorst, CM | 1 |
| Bare, RM | 1 |
| Ohshima, M | 1 |
| Nims, RW | 2 |
| Hu, H | 1 |
| Lubet, RA | 2 |
| Devor, DE | 1 |
8 other studies available for barbital and Cancer of Liver
| Article | Year |
|---|---|
[Establishment of test methods for examining promoters of hepatocarcinogenesis--promoting effects of phenobarbital, butylated hydroxytoluene and barbital].
Topics: Animals; Barbital; Barbiturates; Butylated Hydroxytoluene; Cocarcinogenesis; Diethylnitrosamine; Liv | 1984 |
Transplacental carcinogenesis by cisplatin in F344/NCr rats: promotion of kidney tumors by postnatal administration of sodium barbital.
Topics: Animals; Barbital; Body Weight; Carcinogenicity Tests; Carcinogens; Cisplatin; Drug Synergism; Femal | 1995 |
Multiorgan transplacental and neonatal carcinogenicity of 3'-azido-3'-deoxythymidine in mice.
Topics: Animals; Animals, Newborn; Anti-HIV Agents; Barbital; Body Weight; Carcinogens; Dose-Response Relati | 1999 |
Apoptosis and cell proliferation in rat hepatocytes induced by barbiturates.
Topics: Animals; Apoptosis; Barbital; Barbiturates; Body Weight; Bromodeoxyuridine; Cell Division; Hepatomeg | 2000 |
Anticarcinogenic effects of cadmium in B6C3F1 mouse liver and lung.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Barbital; Cadmium; Cadmium Chloride; Diethylni | 1991 |
Promotion by sodium barbital of renal cortical and transitional cell tumors, but not intestinal tumors, in F344 rats given methyl(acetoxymethyl)nitrosamine, and lack of effect of phenobarbital, amobarbital, or barbituric acid on development of either rena
Topics: Adenoma; Amobarbital; Animals; Barbital; Barbiturates; Carcinogens; Carcinoma; Carcinoma, Renal Cell | 1989 |
Tumor promoting activities of ethylphenylacetylurea and diethylacetylurea, the ring hydrolysis products of barbiturate tumor promoters phenobarbital and barbital, in rat liver and kidney initiated by N-nitrosodiethylamine.
Topics: Animals; Barbital; Body Weight; Carcinogens; Cytochrome P-450 Enzyme System; Diethylnitrosamine; Enz | 1989 |
Induction of alkoxyresorufin O-dealkylases, epoxide hydrolase, and liver weight gain: correlation with liver tumor-promoting potential in a series of barbiturates.
Topics: 7-Alkoxycoumarin O-Dealkylase; Amobarbital; Animals; Barbital; Barbiturates; Cytochrome P-450 CYP2B1 | 1987 |